FDA Clearance Tracker · K202940
First Relief v1
Last checked: Nov 19, 2026Latest source record: Dec 29, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Dec 29, 2020
Substantially Equivalent
Time to decision
90 days
Received Sep 30, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K202940
- Device name
- First Relief v1
- Applicant
- Dyansys, Inc.
- Applicant location
- San Mateo, CA
- Received
- Sep 30, 2020
- Decided
- Dec 29, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs) (QHH)
- Device class
- Class II
- Regulation
- 21 CFR 876.5340
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QHH. The earliest in FDA's data is DEN180057, decided Jun 7, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K202940
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Dyansys, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Primary Relief510(k)
K221425 · Decided Sep 13, 2022 · 120 days after receipt
Device type: Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief (NHI) · Neurology & Neurosurgery
- Drug Relief v1510(k)
K221231 · Decided Jun 6, 2022 · 38 days after receipt
Device type: Percutaneous Nerve Stimulator For Opioid Withdrawal (PZR) · Neurology & Neurosurgery
- ANSiStim-PP510(k)
K220397 · Decided May 12, 2022 · 90 days after receipt
Device type: Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief (NHI) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.